Sanofi is has struck a five-year strategic alliance with drug discovery company Evotec – which will also be a boost for Evotec's partners, as the company will gain access to Sanofi's library of more than 1 million small molecules.
The French drug maker will commit €250m to Evotec, to be paid out over the next five years; this includes an undefined upfront payment
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?